News > Zydus Cadila begins human trials of COVID-19 vaccine
Zydus Cadila begins human trials of COVID-19 vaccine
News | 16/07/2020 08:50 AM | Click to read full article
Zydus is only the second Indian pharma firm to get DCGI’s nod for human trials of its vaccine candidate. It has started human trials of ZyCoV-D. The company will be enrolling over 1,000 subjects across multiple clinical study sites in India.
The adaptive phase I/ II human clinical trials of ZyCoV-D have commenced with the first human dosing, adding that the adaptive phase I/II dose escalation, multi-centric study will assess the safety, tolerability and immunogenicity of the vaccine.